Scottsdale, Arizona 2/2/2010 3:07:08 AM
News / Finance

QuantRx Biomedical Corp. (QTXB.OB) to Acquire NuRx Pharmaceuticals (NUXP.OB)

QualityStocks would like to highlight QuantRx Biomedical Corp. (OTCBB: QTXB). The company is focused on the development and commercialization of innovative products for advanced diagnosis of serious disease and health conditions. With synergistic expertise in the discovery of diagnostic platforms leveraging a vast portfolio of intellectual property, QuantRx’s mission is to introduce products for use by medical professionals, institutions, and consumers that deliver more accurate, reliable, and faster diagnoses which result in improved patient care and a reduction in overall healthcare costs.

 

In the company’s news Friday,

 

QuantRX Biomedical Corp. announced that it has entered into an agreement to acquire NuRx Pharmaceuticals Inc. (OTCBB: NUXP). The transaction is structured as a tax-free, all stock acquisition resulting in a combined company with no debt and a simplified ownership and capital structure.

 

The agreement for QuantRx to acquire NuRx follows a joint venture between the companies announced in July 2009. The QN Diagnostics joint venture between the two firms leverages 30 years of diagnostic healthcare research and development expertise. The joint venture has been focused on accelerating the commercialization of diagnostic products utilizing QuantRx’s RapidSense rapid diagnostics technology.

 

Among the initial products projected to be launched in 2010 is a new line of hypersensitive clinical laboratory improvement amendments (CLIA) waived quantitative point-of-care lateral flow diagnostic devices. These devices have reliable and repeatable sensitivity in the low picograms per milliliter needed to provide laboratory level results to the point-of-care market. This unique platform technology enables the use of any biological sample such as blood, urine or saliva to deliver laboratory results to the primary care provider in minutes.

 

Through this joint venture, both companies gained a greater appreciation of the point-of-care market and realized that a merger made sense. Both companies believe the merger will not only leave them stronger financially, but will enable them to more aggressively expand their efforts to capitalize on opportunities for their patented diagnostic products in the rapidly growing market for point-of-care diagnostic products.

 

About QualityStocks

 

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

 

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

 

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.